Page last updated: 2024-09-03

pramipexole and Hyperprolactinaemia

pramipexole has been researched along with Hyperprolactinaemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glenmullen, J; Mattison, DR; Moore, TJ1
Ishitobi, M; Kosaka, H; Murata, T; Shukunami, K; Wada, Y1
Bankowski, BJ; Zacur, HA1
Domae, M; Furukawa, T; Hanabusa, Y; Matsumoto, S; Yamada, K1

Reviews

1 review(s) available for pramipexole and Hyperprolactinaemia

ArticleYear
Dopamine agonist therapy for hyperprolactinemia.
    Clinical obstetrics and gynecology, 2003, Volume: 46, Issue:2

    Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles

2003

Other Studies

3 other study(ies) available for pramipexole and Hyperprolactinaemia

ArticleYear
Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    JAMA internal medicine, 2014, Volume: 174, Issue:12

    Topics: Adult; Aged; Aripiprazole; Benzothiazoles; Compulsive Behavior; Consumer Behavior; Dopamine Agonists; Drug Labeling; Female; Gambling; Humans; Hyperprolactinemia; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Piperazines; Pramipexole; Quinolones; Receptors, Dopamine D3; Restless Legs Syndrome; Retrospective Studies; Sexual Behavior; United States; United States Food and Drug Administration

2014
Adjunctive treatment with low-dosage pramipexole for risperidone-associated hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:2

    Topics: Adult; Benzothiazoles; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hyperprolactinemia; Male; Pramipexole; Risperidone; Schizophrenia

2011
Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
    European journal of pharmacology, 1990, Apr-10, Volume: 179, Issue:1-2

    Topics: Animals; Azepines; Benzamides; Benzothiazoles; Dopamine Antagonists; Dose-Response Relationship, Drug; Estrogen Antagonists; Hyperprolactinemia; Injections, Subcutaneous; Male; Perfusion; Pituitary Gland, Anterior; Pramipexole; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Dopamine D2; Thiazoles

1990